Adamed Group attends CPhI Worldwide 2012

12 October 2012

The Adamed Group had an occasion to share its experience and establish new business relationships with representatives of companies from many countries. During the event, representatives of Adamed followed the latest global trends in the pharmaceutical market and held several meetings with potential partners in the industry. This work resulted a number of new contracts for licensed products. Cilostazol and Amlodipine - Ramipril attracted the most amount of attention from all of the products offered by the company.

CPhI gave the company an opportunity to strengthen existing relationships with partners from China, Hungary and countries in the Middle East, with which the Adamed Group had a chance to discuss cooperation so far and jointly think about steps for the future. Attending an international event such as this has once again given the company an opportunity to directly and effectively reach international partners and get them interested in the Polish pharmaceutical and biotechnological market.

Next year, CPhI Worldwide will take place in Frankfurt on October 22nd – 24th, 2013.

Development and innovation
15 October 2012
Prizes and awards
9 October 2012